Higher Medtech Fees In Philippines Will Support Ongoing Regulatory Improvements
Executive Summary
Medtech regulatory fees in the Philippines are being increased for the first time since 2001. The country's FDA says the new fees will support quality improvements.
You may also be interested in...
Asia Reg Roundup: Philippines Sets Short Reg System Deadline, Vietnam Defers, Malaysia Extends
New regulatory systems for devices are proliferating in the ASEAN and South-East Asia region. Some have set short compliance deadlines that have turned out to be unworkable. Will the Philippines, which in January issued an Administrative Order establishing a new risk-based regulatory system, suffer the same fate? Medtech Insight discussed the issue with local regulatory experts Jack Wong and May Ng.
Seven Trending Technologies On The Cusp Of Mainstream Uptake
At HIMSS22, NEO.Life’s Jane Metcalfe identified seven trending technologies that are set to move from the fringes of medicine to the center of attention.
Regulation, Digitization Mulled As Swiss Medtechs Look To An ‘EU+’ Vision For The Future
With Switzerland now operating as a third country to the EU, Swiss-based medtech manufacturers are keen to maximize their inherent advantages and build a basis for future growth.